Hesse's "Pepper Priscamine Tablets" was the first review.

Text . . . On October 9th, NMPA released approval showing that Hesco's class 4 generic drug", "Pythoprystamin tablets", was approved for sale, becoming the second domestic approval of the variety, and becoming the first to be evaluated as if it had passed a consistent evaluation.
, developed by Svea Servier, is a third-generation angiotensin conversion enzyme (ACE) inhibitor and one of the first-line, long-acting antihypertensive drugs for hypertension and congestive heart failure.
the product was first introduced in Europe in 1988 in the form of pyrithroid salts and was first approved for sale in China in 1999 under the name Asda.
the Insight database shows that at present, only Schweija's products as the original research real estate varieties as if through a consistent evaluation.
only one generic drug approved for the market, from Shanghai Pharmaceuticals Dongying, but it was launched earlier, in 2009, and has not yet passed a consistent evaluation.
application submitted by the Company on December 25, 2019 was accepted by CDE and is currently under review and approval.
's new registration classification was approved, meaning it became the first in the country to review the drug.
from: Insight Database ()